Jan 12, 2021
Consistent benefit regardless of CKD etiology
Once, in the not-too-distant past, one could not scan the latest issue of any top-tier medical journal without finding at least one trial extolling the benefits of statin therapy, which lead many to suggest and not always facetiously that it was time to add statins to the water.
Since late summer 2019 when the results of DAPA-HF were reported at the 2019 European Society of Cardiology Congress in Paris, SGLT2 inhibitors have displaced statins as the pharmaceutical of choice for those who like the “one-drug-fits-all-conditions” approach to the art of medicine.
The latest entry comes from David C. Wheeler, MB, ChB, MD of the George Institute for Global Health in Sydney, Australia, who with his co-investigators offers another look at the findings from DAPA-CKD in
Respicardia Announces Highmark Coverage for the remed (R) System in Patients with Central Sleep Apnea grandrapidsmn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from grandrapidsmn.com Daily Mail and Mail on Sunday newspapers.
Respicardia Announces Highmark Coverage for the remedē® System in Patients with Central Sleep Apnea
Expanded insurance coverage now available in Pennsylvania, Delaware and West Virginia
News provided by
Share this article
Share this article
MINNETONKA, Minn., Jan. 7, 2021 /PRNewswire/ Respicardia, Inc., the manufacturer of the only FDA-approved active implantable system for the treatment of central sleep apnea (CSA), announced today that Highmark Blue Cross Blue Shield and its affiliates will provide coverage for the Company s
remedē® System therapy, effective immediately. Highmark provides health insurance coverage to over 5 million individuals across Pennsylvania, Delaware and West Virginia.
The remedē® System We are pleased by this coverage decision from Highmark as it provides needed member access to this proven therapy option said Peter Sommerness, CEO of Respicardia. With published clinical data demonstrating sustained safety and efficacy treating CSA throu
email article
A certain number of heart attacks, strokes, and other unrelated incidents soon after vaccination are to be expected statistically, but how can those anecdotes avoid becoming anti-vaccine fodder? (
STAT)
Maintaining oral anticoagulation through transcatheter aortic valve replacement actually was associated with fewer transfusions and no more bleeding or vascular complications in a large European series. (
JACC: Cardiovascular Interventions)
Lower superficial temporal artery access for coronary angiography and interventions is feasible in COVID-19 patients when standard sites aren t readily accessible. (
European Heart Journal Case Reports)
The University of Florida basketball player who collapsed on the court during a game earlier this month was diagnosed with acute myocarditis potentially linked to COVID-19 infection over the summer. (
I had no idea what lay in store on the day I was confirmed Covid‐19 positive
Dr Emer Joyce has written about her experiences both as patient and medic, specifically about SARS‐CoV‐2 myocarditis, inflammation of the heart muscle
Dr Emer Joyce said new understanding of the disease was emerging and there were still fears over possible long-term consequences for patients.
Mon, 14 Dec, 2020 - 14:45
Noel Baker, Social Affairs Correspondent
A leading cardiologist and heart expert has described contracting Covid-19 and said: I feel as if I know less now than before this all started .
Dr Emer Joyce has written about her experiences both as patient and medic, specifically about SARS‐CoV‐2 myocarditis, inflammation of the heart muscle.